12-Chemokine Gene Signature Identifies Lymph Node-Like Structures in Melanoma: Potential for Patient Selection for Immunotherapy?

Scientific Reports - United Kingdom
doi 10.1038/srep00765
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Correction To: Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma

Current Treatment Options in Oncology
OncologyPharmacology
2019English

Sentinel Lymph Node Biopsy in Cutaneous Melanoma

Acta Cirurgica Brasileira
Surgery
2007English

A Gene Expression Signature of Invasive Potential in Metastatic Melanoma Cells

PLoS ONE
Multidisciplinary
2009English

Elective Lymph Node Dissection in Patients With Melanoma

Archives of Surgery
2002English

Groin Lymph Node Metastases in Pedal Melanoma in Nigeria

Cancer therapy & Oncology International Journal
2018English

P1.04-12 Mass Spectrometry-Based Serum Proteomic Signature as a Potential Biomarker for Survival in NSCLC Patients With Immunotherapy

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Advances in Immunotherapy for Melanoma

BMC Medicine
Medicine
2016English

Impact of Completion Lymph Node Dissection on Patients With Positive Sentinel Lymph Node Biopsy in Melanoma

Journal of the American College of Surgeons
Surgery
2016English

Combination Immunotherapy for Melanoma

JAMA Oncology
Cancer ResearchOncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy